Cyprotex plc Company Profile (LON:CRX)

About Cyprotex plc (LON:CRX)

Cyprotex plc logoCyprotex PLC is a holding company. The Company and its subsidiaries are engaged in the provision of in vitro and in silico Absorption, Distribution, Metabolism, Excretion, Toxicity (ADMET) and Pharmacokinetic (PK) information to the pharmaceutical and biotechnology industries. It offers a range of different services in the areas of ADME-PK, in vitro toxicology, biosciences, in silico prediction, in vitro skin and ocular testing, endocrine disruption and physicochemical profiling. Its in vitro ADME and drug metabolism and pharmacokinetics (DMPK) services include in vitro metabolism, in vitro permeability and transporters, solubility and physicochemical properties, in vitro protein binding and PK and bioanalysis. It operates mainly in North America, Mainland Europe and the United Kingdom. It serves pharmaceutical, biotech, cosmetics, personal care, household products, chemical, agrochemical and tobacco markets. Its subsidiaries include Cyprotex Discovery Limited and Cyprotex US, LLC.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Symbol: LON:CRX
  • CUSIP: N/A
  • Web: www.cyprotex.com/
Average Prices:
  • 50 Day Moving Avg: GBX 158.05
  • 200 Day Moving Avg: GBX 139.36
  • 52 Week Range: GBX 79.22 - GBX 160.50
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Profitability:
  • Net Margins: 33.85%
  • Return on Assets: 36.87%
Misc:
  • Average Volume: 21,791 shs.
 

Frequently Asked Questions for Cyprotex plc (LON:CRX)

What is Cyprotex plc's stock symbol?

Cyprotex plc trades on the London Stock Exchange (LON) under the ticker symbol "CRX."

Who are some of Cyprotex plc's key competitors?

How do I buy Cyprotex plc stock?

Shares of Cyprotex plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Cyprotex plc's stock price today?

One share of Cyprotex plc stock can currently be purchased for approximately GBX 160.50.


MarketBeat Community Rating for Cyprotex plc (LON CRX)
Community Ranking:  0.7 out of 5 ()
Outperform Votes:  15 (Vote Outperform)
Underperform Votes:  92 (Vote Underperform)
Total Votes:  107
MarketBeat's community ratings are surveys of what our community members think about Cyprotex plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cyprotex plc (LON:CRX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cyprotex plc (LON:CRX)
Show:
DateFirmActionRatingPrice TargetDetails
11/17/2015N+1 SingerReiterated RatingcorporateView Rating Details
(Data available from 9/22/2015 forward)

Earnings

Earnings History for Cyprotex plc (LON:CRX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Cyprotex plc (LON:CRX)
Current Year EPS Consensus Estimate: $6.40 EPS

Dividends

Dividend History for Cyprotex plc (LON:CRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cyprotex plc (LON:CRX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Cyprotex plc (LON:CRX)
Latest Headlines for Cyprotex plc (LON:CRX)
Source:

Social

Social activity is not available for this stock.

Chart

Cyprotex plc (CRX) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by MarketBeat.com Staff